Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome

Journal of Parenteral and Enteral Nutrition

Volumn 34, Issue 5, 2010, Pages 513-520

  Goulet, Olivier ^a   Dabbas Tyan, Myriam ^a   Talbotec, Cécile ^a   Kapel, Nathalie ^b   Rosilio, Myriam ^c   Souberbielle, Jean Claude ^a   Corriol, Odile ^a   Ricour, Claude ^a   Colomb, Virginie ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Lilly France   (France)

Author keywords

parenteral nutrition; recombinant human growth hormone; recommended dietary allowances; short bowel syndrome

Indexed keywords

CITRULLINE; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ABSENCE OF SIDE EFFECTS; AMINO ACID BLOOD LEVEL; ARTICLE; BODY COMPOSITION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; ENERGY BALANCE; ENTERIC FEEDING; FEMALE; FOLLOW UP; HUMAN; INSULIN BLOOD LEVEL; INTESTINE ABSORPTION; INTESTINE FUNCTION; MALE; NEWBORN DISEASE; PARENTERAL NUTRITION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SHORT BOWEL SYNDROME; TREATMENT DURATION; TREATMENT RESPONSE; WEANING;

BODY COMPOSITION; CHILD; CHILD, PRESCHOOL; CITRULLINE; ENERGY INTAKE; ENERGY METABOLISM; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL ABSORPTION; INTESTINES; MALE; PARENTERAL NUTRITION, TOTAL; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SHORT BOWEL SYNDROME;

EID: 78649843834     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607110362585     Document Type: Article

References (67)

1. Goulet O., Ruemmele F. Causes and management of intestinal failure. Gastroenterology. 2006 ; 130 (2 suppl 1). S16 - S28.
2. Quiros-Tejeira RE, Ament ME, Reyen L., et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr. 2004 ; 145: 157-163.
3. Goulet O., Baglin-Gobet S., Jais JP, et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg. 2005 ; 15: 95-101.
4. Spencer AU, Neaga A., West B., et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg. 2005 ; 242: 403-409.
5. Wales PW, de Silva N., Kim JH, et al. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005 ; 40: 755-762.
6. Diamond IR, de Silva N., Pencharz PB, et al. Group for the Improvement of Intestinal Function and Treatment. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg. 2007 ; 42: 806-811.
7. Lloyd DA, Vega R., Bassett P., et al. Survival and dependence on home parenteral nutrition: experience over a 25-year period in a UK referral centre. Aliment Pharmacol Ther. 2006 ; 24: 1231-1240.
8. Colomb V., Dabbas-Tyan M., Taupin P., et al. Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients. J Pediatr Gastroenterol Nutr. 2007 ; 44: 347-353.
9. Wales PW Surgical therapy for short bowel syndrome. Pediatr Surg Int. 2004 ; 20: 647-657.
10. DiBaise JK, Young RJ, Vanderhoof JA Intestinal rehabilitation and the short bowel syndrome: part 2. Am J Gastroenterol. 2004 ; 99: 1823-1832.
11. Javid PJ, Kim HB, Duggan CP, Jaksic T. Serial transverse enteroplasty is associated with successful short-term outcomes in infants with short bowel syndrome. J Pediatr Surg. 2005 ; 40: 1019-1023.
12. Ehrlich PF, Mychaliska GB, Teitelbaum DH The 2 STEP: an approach to repeating a serial transverse enteroplasty. J Pediatr Surg. 2007 ; 42: 819-822.
13. Sudan D., DiBaise J., Torres C., et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg. 2005 ; 9: 165-176.
14. Torres C., Sudan D., Vanderhoof J., et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr. 2007 ; 45: 204-212.
15. American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology. 2003 ; 124: 1105-1110.
16. Goulet O., Ruemmele F., Lacaille F., Colomb V. Irreversible intestinal failure in children. J Pediatr Gastroenterol Nutr. 2004 ; 38: 250-269.
17. Grant D., Abu-Elmagd K., Reyes J., et al. on behalf of the Intestine Transplant Registry. 2003 report of the Intestine Transplant Registry: a new era has dawned. Ann Surg. 2005 ; 241: 607-613.
18. Goulet O., Sauvat F., Ruemmele F., et al. Results of the Paris program: ten years of pediatric intestinal transplantation. Transplant Proc. 2005 ; 37: 1667-1670.
19. Pironi L., Hebuterne X., Van Gossum A., et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol. 2006 ; 101: 1633-1643.
20. Sauvat F., Dupic L., Caldari D., et al. Factors influencing outcome after intestinal transplantation in children. Transplant Proc. 2006 ; 38: 1689-1691. (Pubitemid 44190037)
21. Pironi L., Forbes A., Joly F., et al. Home Artificial Nutrition Working Group of the European Society for Clinical Nutrition and Metabolism (ESPEN). Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology. 2008 ; 135: 61-71.
22. Lund PK Molecular basis of intestinal adaptation: the role of the insulin-like growth factor system. Ann N Y Acad Sci. 1998 ; 859: 18-36.
23. Wilmore DW Growth factors and nutrients in the short bowel syndrome. JPEN J Parenter Enteral Nutr. 1999 ; 23 (5 suppl). S117 - S120.
24. Bastie MJ, Balas D., Laval J., et al. Histological variations of jejunal and ileal mucosa on days 8 and 15 after hypophysectomy in rat: morphometrical analysis in light and electron microscopy. Acta Anat. 1982 ; 112: 321-337.
25. Taylor B., Murphy GM, Dowling RH Pituitary hormones and the small bowel: effect of hypophysectomy on intestinal adaptation to small bowel resection in the rat. Eur J Clin Invest. 1979 ; 9: 115-127.
26. Yeh KY, Moog F. Development of the small intestine in the hypophysectomized rat: growth, histology and activity of alkaline phosphatase, maltase and sucrase. Dev Biol. 1975 ; 97: 156-172.
27. Leblond CP, Carriere R. The effect of growth hormone and thyroxine on the mitotic rate of the intestinal mucosa of the rat. Endocrinology. 1955 ; 56: 261-266.
28. Scow RO, Hagan SN Effect of testosterone propionate and growth hormone on growth and chemical composition of muscle and other tissues in hypophysectomized male rats. Endocrinology. 1965 ; 7: 852-858.
29. Shulman DI, Shih Hu C., Duckett G., Lavallee-Grey M. Effects of short-term growth hormone therapy in rats undergoing 75% small intestinal resection. J Pediatr Gastroenterol Nutr. 1992 ; 14: 3-11.
30. Benhamou PH, Canarelli JP, Leroy C., De Boissieu D., Dupont C. Stimulation by recombinant human growth hormone of growth and development of remaining bowel after subtotal ileojejunectomy in rat. J Pediatr Gastroenterol Nutr. 1994 ; 18: 446-452.
31. Ulshen MA, Dowling RH, Fuller CR, Zimmermann EM, Lund PK Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology. 1993 ; 104: 973-980.
32. Laburthe M., Rouyer-Fessard C., Gammeltoft S. Receptors for insulin-like growth factors I and II in rat gastrointestinal epithelium. Am J Physiol. 1988 ; 254 (3 pt 1). G457 - G462.
33. Termanini B., Nardi RV, Finan TM, Parikh I., Korman LY Insulin-like growth factor receptors in rabbit gastrointestinal tract: characterization and autoradiographic localization. Gastroenterology. 1990 ; 99: 51-60. (Pubitemid 20202489)
34. Lobie PE, Briepohl S., Waters MJ Growth hormone receptors in rat intestinal tract. Endocrinology. 1990 ; 126: 299-306.
35. Selub SE, Jin C., Ulshen MH, Lund PK IGF-I m RNA distribution in rat gastrointestinal tract and growth hormone dependent expression [abstract]. Gastroenterology. 1991 ; 100: A666.
36. Vanderhoof JA, McCusrer RH, Clark R., et al. Truncated and native IGF-I enhance mucosal adaptation after jejunoileal resection. Gastroenterology. 1992 ; 102: 1949-1956.
37. Lemmey AB, Martin AA, Read LC, Tomas FM, Owens PC, Ballard FJ IGF-I and the truncated analogue des-(1-3)IGF-I) enhance growth in rats after gut resection. Am J Physiol. 1991 ; 260 (2 pt 1). E213 - E219.
38. Challacombe DN, Wheeler EE The trophic action of human growth hormone duodenal mucosa cultured in vitro. J Pediatr Gastroenterol Nutr. 1995 ; 21: 50-53.
39. Inoue Y., Copeland EM, Souba WW Growth hormone enhances amino-acid uptake by the human small intestine. Ann Surg. 1994 ; 219: 715-724.
40. Byrne TA, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr. 1995 ; 19: 296-302.
41. Scolapio JS, Camilleri M., Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology. 1997 ; 113: 1074-1081.
42. Ellegard L., Bosaeus I., Nordgren S., Bengtsson BA Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg. 1997 ; 225: 88-96.
43. Szkudlarek J., Jeppesen PB, Mortensen PB Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double blind, crossover, placebo controlled study. Gut. 2000 ; 47: 199-205.
44. Seguy D., Vahedi K., Kapel N., Souberbielle JC, Messing B. Low dose growth hormone in adult home parenteral nutrition-dependent short bowel patients: a positive study. Gastroenterology. 2003 ; 124: 293-302.
45. Guo S., Roche A., Houtkooper L. Fat-free mass in children and young adults predicted from bioelectric impedance and anthropometric variables. Am J Clin Nutr. 1989 ; 50: 435-443.
46. Wootton IDP. Micro-Kjeldahl method. In: Churchill JA, ed. MicroAnalysis in Medical Biochemistry. 4 th ed. London, UK: Churchill ; 1964: 140-143.
47. Kapel N., Matarazzo P., Haouchine D., et al. Fecal tumor necrosis factor alpha, eosinophil cationic protein and IgE levels in infants with cow's milk allergy and gastrointestinal manifestations. Clin Chem Lab Med. 1999 ; 37: 29-32.
48. Van de Kamer JH, Huihink H., Weyers HA Rapid method for determination of fat in feces. J Biol Chem. 1949 ; 177: 347-355.
49. Miller DS, Payne PR A ballistic bomb calorimeter. Br J Nutr. 1959 ; 13: 501-508.
50. Southgate DA, Durnin JV Calorie conversion factors. An experimental reassessment of the factors used in the calculation of the energy value of human diets. Br J Nutr. 1970 ; 24: 517-535.
51. Socha J., Ksiazyk J., Fogel WA, Kierkus J., Lyszkowska M., Sasiak K. Is growth hormone a feasible adjuvant in the treatment of children after small bowel resection ? Clin Nutr. 1996 ; 15: 185-188.
52. Lifschitz C., Duggan C., Lazngston C., Vanderhoof J., Shulman RJ Growth hormone (GH) therapy in children with short bowel syndrome (SBS): a randomized, placebo controlled study. Paper presented at: Digestive Disease Week ; May 17-23, 2003 ; Orlando, FL. Abstract 100.
53. Ladd AP, Grosfeld JL, Pescovitz OH, Johnson NB The effect of growth hormone supplementation on late nutritional independence in pediatric patients with short bowel syndrome. J Pediatr Surg. 2005 ; 40: 442-445.
54. Bianda TL, Glatz Y., Boeni-Schnetzler M., Froesch ER, Schmid C. Effects of growth hormone (GH) and insulin-like growth factor-I on serum leptin in GH- deficient adults. Diabetologia. 1997 ; 40: 363-364.
55. Crenn P., Coudray-Lucas C., Thuillier F., Cynober L., Messing B. Post-absorptive plasma citrulline concentration is a marker of enterocyte mass and intestinal failure in humans. Gastroenterology. 2000 ; 119: 1496-1505.
56. Santarpia L., Catanzano F., Ruoppolo M., et al. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome. Ann Nutr Metab. 2008 ; 53: 137-142.
57. Crenn P., Messing B., Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008 ; 27: 328-339.
58. Jianfeng G., Weiming Z., Ning L., et al. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. J Surg Res. 2005 ; 127: 177-182.
59. Rhoads JM, Plunkett E., Galanko J., et al. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr. 2005 ; 146: 542-547.
60. Guarino A., Canani RB, Iafusco M., Casola A., Rosso R., Rubino A. In vivo and in vitro effects of human growth hormone on rat intestinal ion transport. Pediatr Res. 1995 ; 37: 576-580.
61. Canani RB, Bisceglia M., Bruzzese E., Mallardo G., Guarino A. Growth hormone stimulates, through tyrosine kinase, ion transport and proliferation in human intestinal cells. J Pediatr Gastroenterol Nutr. 1999 ; 28: 315-320.
62. Petersen SR, Holaday NJ, Jeevanandam M. Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma. 1994 ; 36: 726-733.
63. Pinto G., Blanche S., Thiriet I., Souberbielle JC, Goulet O., Brauner R. Growth hormone treatment of children with human immunodeficiency virus-associated growth failure. Eur J Pediatr. 2000 ; 159: 937-938.
64. Copeland KC, Nair KS Acute growth hormone effects on amino acid and lipid metabolism. J Clin Endocrinol Metab. 1994 ; 78: 1040-1047.
65. Luo M., Fernández-Estívariz C., Manatunga AK, et al. Are plasma citrulline and glutamine biomarkers of intestinal absorptive function in patients with short bowel syndrome ? JPEN J Parenter Enteral Nutr. 2007 ; 31: 1-7.
66. Denson LA Growth hormone therapy in children and adolescents: pharmacokinetic/pharmacodynamic considerations and emerging indications. Expert Opin Drug Metab Toxicol. 2008 ; 4: 1569-1580.
67. Bailly-Botuha C., Colomb V., Thioulouse E., et al. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res. 2009 ; 65: 559-563.